Skip to main content
Caplight Logo









Nionyx Bio

Nionyx Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://nionyxbio.com/

Last Round

Seed

Sep 29, 2025

Total Funding Raised

$4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nionyx Bio is a biotechnology company that develops AAV-based gene therapies to address kidney genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyAAVadeno-associated viruscapsid engineeringkidney diseasegenetic medicinegene deliverygene cassettebiotech startupdrug discoveryprecision medicinevector libraryrenal therapeuticsbiotech platformgenetic engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nionyx Bio Comparables

Compare Nionyx Bio with similar companies based on industry and business-model similarity.

Nionyx Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nephrogen
87%
Purespring Therapeutics
80%
Dyno Therapeutics
68%

Nionyx Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 29, 2025

Key People

Founding team and executive leadership

Magdalena Tyrpien

Co-Founder & CEO

Founding Team

Nionyx Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 413% MoM, from 389 to 2K.

  • Apr 21, 2026

    Monthly visitors increased 2859% MoM, reaching 1.4K.

Nionyx Bio Filings

Explore SEC and related filing metadata, where available.

Nionyx Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nionyx Bio's valuation, stock price, and market status.

Is Nionyx Bio a public or private company?

Nionyx Bio is a private company.

What is the current stock price of Nionyx Bio?

Nionyx Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Nionyx Bio worth (valuation)?

Valuation information for Nionyx Bio is not publicly available.

Can I buy Nionyx Bio stock?

Nionyx Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nionyx Bio's last funding round?

Nionyx Bio's most recent funding round was Seed on September 29, 2025.

Who are the main investors in Nionyx Bio?

Key investors in Nionyx Bio include 2048 Ventures.

Will Nionyx Bio IPO soon?

No public IPO plans have been announced for Nionyx Bio.

How can I track Nionyx Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nionyx Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range4
Year Founded2025
Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?